Literature DB >> 31478111

Developing a National Center of Excellence for Prostate Imaging.

Annerleim Walton-Diaz1,2,3, Manuel Madariaga-Venegas4,5, Nicolas Aviles4,6, Juan Carlos Roman4,7,8, Ivan Gallegos4,8, Mauricio Burotto9,10.   

Abstract

PURPOSE OF REVIEW: The purpose of this review is to summarize the most current literature regarding the most important aspects to consider when developing a center of excellence for prostate imaging and biopsy. RECENT
FINDINGS: Multiparametric MRI (mp-MRI) has changed the way we diagnose and treat prostate cancer. This imaging modality allows for more precise identification of areas suspicious in terms of harboring prostate cancer, enabling performance of targeted mp-MRI-guided biopsies that have been demonstrated to yield superior cancer detection rates. Centers worldwide are increasingly adopting this technology. However, obtaining results comparable with those findings published in the literature can be challenging. The imaging and biopsy process entails the need for a multidisciplinary team including a dedicated radiologist, urologist, and pathologist. Adequate mp-MRI interpretation for accurate lesion identification, acquaintance with the biopsy technique selected, and precise characterization of Gleason Score/Grade Groupings are equal determinants of accurate biopsy results. Furthermore, all specialists are required to attain appropriate learning curves to ensure optimal results. In this review, we characterize crucial aspects to consider when developing a center of excellence for prostate imaging and biopsy as well as insights regarding how to implement them.

Entities:  

Keywords:  Biopsy; Fusion; Gleason; ISUP; Multiparametric magnetic resonance image; Prostate

Mesh:

Year:  2019        PMID: 31478111     DOI: 10.1007/s11934-019-0923-3

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  51 in total

1.  Accuracy and agreement of PIRADSv2 for prostate cancer mpMRI: A multireader study.

Authors:  Matthew D Greer; Anna M Brown; Joanna H Shih; Ronald M Summers; Jamie Marko; Yan Mee Law; Sandeep Sankineni; Arvin K George; Maria J Merino; Peter A Pinto; Peter L Choyke; Baris Turkbey
Journal:  J Magn Reson Imaging       Date:  2016-07-08       Impact factor: 4.813

Review 2.  The expanding role of MRI in prostate cancer.

Authors:  Gillian Murphy; Masoom Haider; Sangeet Ghai; Boraiah Sreeharsha
Journal:  AJR Am J Roentgenol       Date:  2013-12       Impact factor: 3.959

Review 3.  A meta-analysis of use of Prostate Imaging Reporting and Data System Version 2 (PI-RADS V2) with multiparametric MR imaging for the detection of prostate cancer.

Authors:  Li Zhang; Min Tang; Sipan Chen; Xiaoyan Lei; Xiaoling Zhang; Yi Huan
Journal:  Eur Radiol       Date:  2017-06-27       Impact factor: 5.315

4.  Assessment of Needle Tip Deflection During Transrectal Guided Prostate Biopsy: Implications for Targeted Biopsies.

Authors:  Daniel Halstuch; Jack Baniel; David Lifshitz; Sivan Sela; Yaara Ber; David Margel
Journal:  J Endourol       Date:  2018-01-26       Impact factor: 2.942

5.  Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with prostate cancer.

Authors:  Lambros Stamatakis; M Minhaj Siddiqui; Jeffrey W Nix; Jennifer Logan; Soroush Rais-Bahrami; Annerleim Walton-Diaz; Anthony N Hoang; Srinivas Vourganti; Hong Truong; Brian Shuch; Howard L Parnes; Baris Turkbey; Peter L Choyke; Bradford J Wood; Richard M Simon; Peter A Pinto
Journal:  Cancer       Date:  2013-07-02       Impact factor: 6.860

6.  The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer.

Authors:  M Norberg; L Egevad; L Holmberg; P Sparén; B J Norlén; C Busch
Journal:  Urology       Date:  1997-10       Impact factor: 2.649

7.  The Learning Curve in Prostate MRI Interpretation: Self-Directed Learning Versus Continual Reader Feedback.

Authors:  Andrew B Rosenkrantz; Abimbola Ayoola; David Hoffman; Anunita Khasgiwala; Vinay Prabhu; Paul Smereka; Molly Somberg; Samir S Taneja
Journal:  AJR Am J Roentgenol       Date:  2016-12-27       Impact factor: 3.959

8.  The use of targeted MR-guided prostate biopsy reduces the risk of Gleason upgrading on radical prostatectomy.

Authors:  Christian Arsov; Nikolaus Becker; Robert Rabenalt; Andreas Hiester; Michael Quentin; Frederic Dietzel; Gerald Antoch; Helmut E Gabbert; Peter Albers; Lars Schimmöller
Journal:  J Cancer Res Clin Oncol       Date:  2015-05-27       Impact factor: 4.553

9.  Defining the optimal method for reporting prostate cancer grade and tumor extent on magnetic resonance/ultrasound fusion-targeted biopsies.

Authors:  Jennifer B Gordetsky; Luciana Schultz; Kristin K Porter; Jeffrey W Nix; John V Thomas; Maria Del Carmen Rodriguez Pena; Soroush Rais-Bahrami
Journal:  Hum Pathol       Date:  2018-03-16       Impact factor: 3.466

Review 10.  Current status of magnetic resonance imaging (MRI) and ultrasonography fusion software platforms for guidance of prostate biopsies.

Authors:  Jennifer K Logan; Soroush Rais-Bahrami; Baris Turkbey; Andrew Gomella; Hayet Amalou; Peter L Choyke; Bradford J Wood; Peter A Pinto
Journal:  BJU Int       Date:  2014-05-22       Impact factor: 5.588

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.